The U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) are investigating a salmonellosis outbreak linked to moringa powder capsules involving an “extensively drug-resistant” strain of Salmonella.

The capsules are sold under the Rosabella brand name and are distributed by Ambrosia Brands LLC.

A total of seven people infected with the outbreak strain have been reported in seven states (Arizona, Florida, Iowa, Illinois, Indiana, Tennessee, and Washington), resulting in three hospitalizations. There have not been any deaths. All three patients who were interviewed reported eating Rosabella-brand moringa powder capsules.

The Salmonella strain associated with this outbreak is resistant to all first-line and alternative antibiotics commonly recommended for the treatment of Salmonella infections.

FDA recommended that Ambrosia Brands LLC recall all Rosabella-brand moringa powder capsules from the market. The firm has agreed to conduct a recall of certain lots. A complete list of lot codes and expiration dates for potentially contaminated product can be found here.

FDA is conducting a traceback investigation to determine the source of contamination and is working with state partners to collect samples.

Derived from the leaves of the Moringa oleifera plant, moringa powder is consumed by some people for its vitamin and mineral content and purported health benefits.